Hannah Saul

Hannah Saul is an accomplished professional in healthcare policy and patient advocacy with extensive experience across various organizations. Currently serving as a Director for Global Policy and Patient Advocacy Group Engagement at Hansa Biopharma since July 2023, Hannah is also a member of ISPEP since September 2024. Previously, Hannah held senior roles at AstraZeneca, including Senior Director of Global Oncology Patient Affairs, where leadership focused on patient-centric approaches in oncology care, and Global Director of Policy and Advocacy in Respiratory Disease, driving healthcare policy initiatives. Prior to AstraZeneca, Hannah served at Celgene, Roche, Bayer Schering Pharma, and Cancerbackup, leading patient advocacy and public affairs efforts across Europe, the Middle East, and Africa. Early career experience includes roles with Action for Blind People and as a Research Assistant for Members of Parliament, complemented by a Bachelor's degree in British Politics and Legislative Studies from the University of Hull.